India Exchange Filings

Supriya Lifescience Q2 FY27 Earnings Summary

Supriya Lifescience Ltd reports Q2 FY27 revenue of ₹206.30 crore, with operating margin at 22.0%

  • Q2 revenue rose 3.2% YoY; EBITDA was ₹45.40 crore and net profit was ₹29.25 crore, versus ₹50.43 crore a year earlier.
  • H1 FY27 revenue increased 14.8% YoY to ₹396.04 crore; EBITDA was ₹92.86 crore and net profit ₹53.29 crore.
  • Margin pressure reflected product and geographic mix, Ambernath ramp-up costs, and elevated raw-material and solvent prices.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.